Trial reportJournal of cosmetic dermatology2025
Efficacy of a Topical Lanolin-Beeswax-Olive Oil Blend (RepoGen Cream) in Preventing Nipple Fissures in Breastfeeding Women: A Randomized Controlled Trial.
Trial report in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy of a Topical Lanolin-Beeswax-Olive Oil Blend (RepoGen Cream) in Preventing Nipple Fissures in Breastfeeding Women: A Randomized Controlled Trial.Journal of cosmetic dermatology · 2025Trial
- Interventions for the Prevention and Management of Nipple Trauma in Breastfeeding Women: A Systematic Review.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesPharmacological and non-pharmacological treatments for nipple fissures have been investigated, with a variety of options yielding promising outcomes. Herbal treatments have also shown effectiveness, albeit with contradictory outcomes. Our objective was to evaluate the effectiveness of a topical blend containing lanolin, beeswax, and olive oil (RepoGen cream) in nipple fissure relief. MATERIAL AND
methodsThis study was a randomized, double-blind, placebo-controlled clinical experiment conducted at a teaching hospital in Qom, Iran, between March 2023 and 2024. Participants were mothers with singleton pregnancies who intended to breastfeed their newborns. The intervention group applied RepoGen cream to the nipple area before and after breastfeeding, while the control group applied placebo cream with no active ingredients. At 3 and 7 days postpartum, women and newborns were evaluated for nipple complications and breastfeeding behaviors and function.
resultsA total of 133 mother-infant dyads were enrolled, with 63 assigned to the RepoGen group and 70 to the control group. The RepoGen group demonstrated significantly lower nipple pain on both Day 3 (63.5% vs. 42.9%, p < 0.001) and Day 7 (84.1% vs. 71.4%, p = 0.01). The incidence of nipple wounds was also significantly reduced in the intervention group at both time points. Multivariate logistic regression analysis confirmed significantly lower odds of nipple pain, redness, wounds, and bleeding in the RepoGen group on Day 3, with sustained reductions in redness and wounds on Day 7. Although feeding frequency did not differ significantly between groups, the RepoGen group exhibited a significantly lower number of wet diapers on both days (p < 0.001). No maternal or neonatal adverse effects were reported throughout the study period.
conclusionThe current study confirmed the effectiveness of RepoGen cream for routine care in relieving nipple fissure symptoms among breastfeeding mothers without causing adverse effects. These findings suggest that RepoGen is a safe and effective intervention for improving maternal breastfeeding comfort during the early postpartum period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.